Abstract:HomeStrokeVol. 53, No. 9Treatment and 1-Year Prognosis of Ischemic Stroke in China in 2018: A Hospital-Based Study From Bigdata Observatory Platform for Stroke of China Free AccessResearch ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissionsDownload Articles + Supplements ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toSupplemental MaterialFree AccessResearch ArticlePDF/EPUBTreatment and 1-Year Prognosis of Ischemic Stroke in China in 2018: A Hospital-Based Study From Bigdata Observatory Platform for Stroke of China Wen-Jun Tu, Feng Yan, Bao-Hua Chao, Lei Cao and Longde Wang Wen-Jun TuWen-Jun Tu https://orcid.org/0000-0002-1703-1802 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China (W.-J.T.). The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China (W.-J.T., F.Y., B.-H.C., L.C., L.W.). , Feng YanFeng Yan The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China (W.-J.T., F.Y., B.-H.C., L.C., L.W.). , Bao-Hua ChaoBao-Hua Chao The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China (W.-J.T., F.Y., B.-H.C., L.C., L.W.). , Lei CaoLei Cao The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China (W.-J.T., F.Y., B.-H.C., L.C., L.W.). and Longde WangLongde Wang Correspondence to: Longde Wang, MD, No. 118, Guang'anmen Inner St, Beijing, 100053, China. Email E-mail Address: [email protected] https://orcid.org/0000-0002-2156-7909 The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China (W.-J.T., F.Y., B.-H.C., L.C., L.W.). Originally published22 Jul 2022https://doi.org/10.1161/STROKEAHA.121.038260Stroke. 2022;53:e415–e417Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: July 22, 2022: Ahead of Print Stroke is associated with the highest disability-adjusted life years lost in China, with over 2 million new cases annually.1 In addition, deaths caused by stroke are rising rapidly in China, more so than in other countries.2 However, there are few studies that have provided nationwide data on stroke treatment and outcomes in China. This study aims to assess the treatment and 1-year prognosis of ischemic stroke in China in 2018.MethodsIn December 2017, we randomly selected 100 hospitals (at least one in each province) from the Bigdata Observatory Platform for Stroke of China3 (Supplemental Material I). Hospitals participating in the Bigdata Observatory Platform for Stroke of China included mandatory and voluntary. From January to December 2018, all patients with first-ever ischemic stroke and symptom onset within 14 days were included. The Ethics Committee of Brain Hospital of Hunan Province (No. Z2017006) and Peking Union Medical College Hospital (JS-2289) approved this study, and written informed consent was obtained. A complete description of the information collected has been reported previously.3 Telephone follow-up was conducted after 1 year after baseline. Case fatality, disability, and recurrence rates were assessed, and a percentage and 95% CIs were presented. Multivariable logistic regression was used to examine the association of variables with the odds of outcomes (Supplemental Material II).ResultsIn total, 74 904 ischemic strokes from 83 hospitals from 30 provinces (median [interquartile range] age, 68 [58–74] years; 61.27% male) were recruited. Two thousand six hundred eighty-nine (3.59% [95% CI, 3.46%–3.72%]) patients received thrombolytic therapy and 820 (1.09%) patients received thrombectomy treatment. At discharge, the fatality rate was 1.23% (95% CI, 1.15%–1.31%). The discharge against medical advice rate was 5.34% (95% CI, 5.18%–5.50%; Table S1). In-hospital fatality rate was higher in those old patients (≥60 years) than in those young patients (<60 years). There were regional differences in the in-hospital fatality rate (Figure).Download figureDownload PowerPointFigure. Subgroup analysis in the discharge and 1-y follow-up (those results were unweighted data as % [95% CI]). Disability was defined as an modified Rankin Scale (mRS) of 3 to 5 points. bModel covariates were age, sex, history of stroke, hypertension, diabetes, hyperlipidemia, atrial fibrillation, coronary artery disease, coagulopathy, heart failure, peripheral arterial disease, carotid stenosis, hyperhomocysteinemia, stroke severity, hospital grade, region, stroke unit, and teaching hospital status. Sex: female vs male; age: ≥60 vs <60. cThe highest-level region vs lowest region; in-hospital fatality: Northwest China (NW) vs CC, in-hospital fatality/discharge against medical advice (DAMA): SW vs NC; 1-year fatality: SC vs North China (NC), 1-year recurrence: Northeast China (NE) vs SC, 1-year disability: SC vs NC. d,e,fRepresent the P for each region compared with North China (NC), which we have selected as the reference region; dFor P<0.05, efor P<0.01, and ffor P<0.001. CC indicates Central China; EC, East China; N, number of patients; n, number of hospitals; and SW, Southwest China.During the follow-up period, the fatality rate was 6.81% (95% CI, 6.62%–7.00%; Table S2. The fatality rate was higher in those old patients than in those young patients. In addition, men patients had a lower fatality rate than women. The fatality rate varied significantly between different regions (Figure). The case recurrence rate was 7.74% (95% CI, 7.54%–7.94%), and the disability rate of stroke survivors was 15.42% (95% CI, 15.14%–15.70%; Table S2). Stroke recurrence rate and disability rate of stroke survivors were higher in those old patients than in those young patients and varied greatly between different regions (Figure).DiscussionThis nationwide study shows the rate of thrombolytic therapy and 1-year outcomes in patients with ischemic stroke. Another study showed that the in-hospital death/discharge against the medical advice rate was 5.3% (5.0%–5.5%) for ischemic stroke.4 The China Kadoorie Biobank showed that among those who survived 28 days after the first stroke, the 1-year case fatality and recurrence rates were 4% and 17%.5 The prognosis of ischemic stroke in China is better than in high-income countries despite the low thrombolytic rates.1 Furthermore, the fatality and disability rates trend are low in north China and high in the south, while the recurrence rate shows the opposite direction. Hospitals with a low sample size and low follow-up rate were excluded. This may cause selection bias as patients in these excluded hospitals might have less access to treatment and worse outcomes. This study provides a scientific basis for the Chinese population by establishing a database of stroke patients in China, studying the rules and trends of disease treatment and prognosis.Article InformationSources of FundingThis study was supported by the National Major Public Health Service Projects.Supplemental MaterialBigdata Observatory Platform for Stroke of ChinaSupplemental Materials and MethodsTables S1–S2FootnotesSupplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/STROKEAHA.121.038260.Correspondence to: Longde Wang, MD, No. 118, Guang'anmen Inner St, Beijing, 100053, China. Email wangld@nhfpc.gov.cnReferences1. Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, Sandercock P, Wang Y, Huang Y, Cui L, et al; China Stroke Study Collaboration. Stroke in China: advances and challenges in epidemiology, prevention, and management.Lancet Neurol. 2019; 18:394–405. doi: 10.1016/S1474-4422(18)30500-3CrossrefMedlineGoogle Scholar2. Li Z, Jiang Y, Li H, Xian Y, Wang Y. China's response to the rising stroke burden.BMJ. 2019; 364:l879. doi: 10.1136/bmj.l879CrossrefMedlineGoogle Scholar3. Shen Y, Chao BH, Cao L, Tu WJ, Wang LD. Stroke center care and outcome: results from the CSPPC stroke program.Transl Stroke Res. 2020; 11:377–386. doi: 10.1007/s12975-019-00727-6CrossrefGoogle Scholar4. Tu WJ, Chao BH, Ma L, Yan F, Cao L, Qiu H, Ji XM, Wang LD. Case-fatality, disability and recurrence rates after first-ever stroke: a study from bigdata observatory platform for stroke of China.Brain Res Bull. 2021; 175:130–135. doi: 10.1016/j.brainresbull.2021.07.020CrossrefGoogle Scholar5. Chen Y, Wright N, Guo Y, Turnbull I, Kartsonaki C, Yang L, Bian Z, Pei P, Pan D, Zhang Y, et al. Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0· 5 million Chinese adults.Lancet Glob Health. 2020; 8:e580–e590. doi: 10.1016/S2214-109X(20)30069-3CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Tu W and Xu Y (2023) A response to a letter to the editor TR-D-22-00887, Thrombosis Research, 10.1016/j.thromres.2023.01.009, 223, (34-35), Online publication date: 1-Mar-2023. Tu W, Xu Y, Chen H, Li J and Du J (2023) Impact of the COVID-19 pandemic lockdown on hospitalizations for cerebrovascular disease and related in-hospital mortality in China: A nationwide observational study, Archives of Gerontology and Geriatrics, 10.1016/j.archger.2022.104832, 104, (104832), Online publication date: 1-Jan-2023. Tu W, Xu Y, Liu Y, Du J and Zhao J (2022) Endovascular thrombectomy or bridging therapy in minor ischemic stroke with large vessel occlusion, Thrombosis Research, 10.1016/j.thromres.2022.09.020, 219, (150-154), Online publication date: 1-Nov-2022. September 2022Vol 53, Issue 9 Advertisement Article InformationMetrics © 2022 American Heart Association, Inc.https://doi.org/10.1161/STROKEAHA.121.038260PMID: 35866427 Originally publishedJuly 22, 2022 Keywordsischemic strokeprognosisdisability-adjusted life yearshospitaltreatment outcomePDF download Advertisement SubjectsIschemic Stroke

Abstract:HomeStrokeVol. 51, No. 5Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBChallenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak Jing Zhao, Anthony Rudd and Renyu Liu Jing ZhaoJing Zhao From the Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China (J.Z.) , Anthony RuddAnthony Rudd Correspondence to Anthony Rudd, Stroke Medicine, Kings College London, United Kingdom, Email E-mail Address: [email protected] https://orcid.org/0000-0002-5738-2703 Stroke Medicine, Kings College London, United Kingdom (A.R.) and Renyu LiuRenyu Liu Renyu Liu, MD, PhD, Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania, 336 John Morgan Bldg, 3620 Hamilton Walk, Philadelphia, PA 19104, Email E-mail Address: [email protected] https://orcid.org/0000-0001-9335-8981 Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (R.L.). Originally published31 Mar 2020https://doi.org/10.1161/STROKEAHA.120.029701Stroke. 2020;51:1356–1357Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: March 31, 2020: Ahead of Print A 60-year-old man with known hypertension went to the supermarket after a few days at home during the community quarantine period for the severe acute respiratory syndrome coronavirus 2–induced disease (COVID-191) in a city in South of China. He was wearing an N95 mask. He developed difficulty in breathing and was dizzy. On the way home, he was unsteady and fell. When he arrived home, he found that his mouth was crooked and although concerned, did not go to the hospital because of his fear of the virus. He went to bed and woke up in the morning with a left-sided hemiparesis. He was sent to a nearby hospital where a magnetic resonance brain scan showed acute cerebral infarction and large blood vessel occlusion. However, this hospital like many others across China understandably did not have adequate relevant experts and resources to perform thrombectomy or arrange proper admission because of the fear of COVID-19 and the shortage of physicians resulting from them being sent to areas with high numbers of COVID-19 cases. In-hospital acquisition of COVID-19 is a huge problem based on recent reports.2,3 His condition continued to deteriorate, and he was transferred to another hospital seeking advanced treatment 2 days later. There are similar stories that patients who have acute stroke have no idea whether to attend hospital and where to go for treatment.With the outbreak of COVID-19, many extreme measures have been taken to contain the spread of the disease, which include converting general medical wards to quarantine wards for patients who contracted the disease, locking down the communities, suspending routine outpatient clinics, stopping all elective procedures, and providing treatment only for very highly selective cases in many areas across China. Over 40 000 medical professionals from all over the China have been sent to the epicenter of the disease. These clinicians include all subspecialties, including neurologists and anesthesiologists, draining resources for other disease conditions. Normal medical care across the country has been seriously impaired with stroke being at the forefront given that it is the top cause of death and disability in the country. Many stroke centers across China have greatly reduced functioning because of fear of in-hospital cross infection and lack of experienced stroke care experts. Our preliminary available data show the number of thrombectomies in Shanghai decreased by 50% in the first month after the Spring Festival compared with the same period in 2019.The epidemic situation of the COVID-19 is still continuing, and there may be similar or worse situations around the world in the future. We would like to recommend the following potential strategies to be implemented as soon as possible to ensure that stroke patients do not suffer as a consequence of emergency response to epidemics taking priority:The establishment of stroke networks and care systems able to deliver high-quality emergency stroke care at all times but particularly at times of crisis.The establishment of centralized stroke treatment centers where sufficient stroke care resource can be secured. Although there is a strong case for such centers to be the system of care at all times, it is particularly important at times of medical crisis to have services that can continue to function. As has been reported in England, the prehospital delay can be actually reduced, and thrombectomy rate can be increased significantly by reducing the number of stroke centers in London.4,5Inform the emergency medical system and the public that these centers will be protected and will remain fully operational even during crises.Improve education of health professionals and the public, especially those who are at high risk of stroke, to recognize stroke and call emergency medical services immediately to be taken to one of the designated stroke centers so as to avoid significant delay in transferring patient from one hospital to the other.During the community, lockdown time use online resources to educate and perform consultation for acute and chronically ill patients to improve stroke prevention awareness and the knowledge of infection prevention.The extent of the COVID-19 epidemic has been so large and widespread that there has been no previous experience that can be used to develop plans for the emergency management of acute stroke treatment (and presumably other acute noninfection-related disease) under such extreme situations. Although the control of the COVID-19 is very important, at the same time, the management of stroke must not be neglected. Over 9000 new stroke cases occur each day in China alone. It cannot be right that treatment for one potentially curable disease is euthanized at the expense of another. With the COVID-19 becoming a pandemic as declared by the World Health Organization on March 11, 2020, the world needs to act quickly to have plans ready to deal with the challenges of continuing to deliver high-quality stroke care.DisclosuresNone.FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to Anthony Rudd, Stroke Medicine, Kings College London, United Kingdom, Email anthony.rudd@kcl.ac.ukRenyu Liu, MD, PhD, Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania, 336 John Morgan Bldg, 3620 Hamilton Walk, Philadelphia, PA 19104, Email renyu.liu@pennmedicine.upenn.eduReferences1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.JAMA. 2020; 323:1061–1069. doi: 10.1001/jama.2020.1585CrossrefMedlineGoogle Scholar2. Chen X, Tian J, Li G, Li G. Initiation of a new infection control system for the covid-19 outbreak.Lancet. 2020; pii:S1473-3099(20)30110-9. doi: 10.1016/S1473-3099(20)30110-9Google Scholar3. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia.N Engl J Med. 2020; 382:1199–1207. doi: 10.1056/NEJMoa2001316CrossrefMedlineGoogle Scholar4. Morris S, Ramsay AIG, Boaden RJ, Hunter RM, McKevitt C, Paley L, et al. Impact and sustainability of centralising acute stroke services in english metropolitan areas: retrospective analysis of hospital episode statistics and stroke national audit data.BMJ. 2019; 364:l1. doi: 10.1136/bmj.l1Google Scholar5. Rudd A. Does size matter? The rationale for centralising acute stroke care into a smaller number of larger units.Transl Perioper & Pain Med. 2019; 6:104–105.Google Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Liu L, Zhou C, Jiang H, Wei H, Zhou Y, Zhou C and Ji X (2024) Epidemiology, pathogenesis, and management of Coronavirus disease 2019-associated stroke, Frontiers of Medicine, 10.1007/s11684-023-1041-7, 17:6, (1047-1067), Online publication date: 1-Dec-2023. Dallas J, Liu K, Wenger T, Lin M, Ding L, Attenello F and Mack W (2023) The effect of COVID-19 on treatment and outcomes following ischemic stroke: A national assessment, Clinical Neurology and Neurosurgery, 10.1016/j.clineuro.2023.107982, 233, (107982), Online publication date: 1-Oct-2023. Dallas J, Wenger T, Liu K, Ding L, Hopkins B, Attenello F and Mack W (2023) Mortality following mechanical thrombectomy for ischemic stroke in patients with COVID-19, Journal of Stroke and Cerebrovascular Diseases, 10.1016/j.jstrokecerebrovasdis.2023.107171, 32:8, (107171), Online publication date: 1-Aug-2023. Hu Q, Hu Y, Gu Y, Song X, Shen Y, Lu H, Zhang L, Liu P, Wang G, Guo C, Fang K and Wang Q (2023) Impact of the COVID‐19 pandemic on acute stroke care: An analysis of the 24‐month data from a comprehensive stroke center in Shanghai, China, CNS Neuroscience & Therapeutics, 10.1111/cns.14148, 29:7, (1898-1906), Online publication date: 1-Jul-2023. Shafer J, Haley K and Jacks A (2022) Accessing information and adapting to the role of care partner for stroke survivors with aphasia during the early Covid-19 pandemic, Aphasiology, 10.1080/02687038.2022.2059055, 37:6, (907-928), Online publication date: 3-Jun-2023. Gajurel B, Giri S, Tamrakar P, Pandeya A, Gautam N, Shrestha A, Karn R, Rajbhandari R and Ojha R (2023)(2023) Stroke patterns and outcomes during the second wave of COVID-19 pandemic: a cross-sectional study, Annals of Medicine & Surgery, 10.1097/MS9.0000000000000722, 85:6, (2490-2495) Ikramuddin F, Melnik T, Ingraham N, Nguyen N, Siegel L, Usher M, Tignanelli C, Morse L and Chen R (2023) Predictors of discharge disposition and mortality following hospitalization with SARS-CoV-2 infection, PLOS ONE, 10.1371/journal.pone.0283326, 18:4, (e0283326) Wang Y, Liu G, Zhu Y, Song H, Ren Y, Liu Y and Ma Q (2023) Impact of the COVID-19 pandemic on emergent stroke care in Beijing, China, Scientific Reports, 10.1038/s41598-023-31530-x, 13:1 Levin O, Vashchilin V, Pikija S, Khasanova D, Turuspekova S, Bogolepova A, Shmonin A, Maltceva M, Vozniuk I, Yanishevskiy S, Huseynov D, Karakulova Y and Obidov F (2023) Current approaches in the treatment and rehabilitation of patients with neurological diseases after COVID-19. Resolution of the International Experts Forum, Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 10.17116/jnevro202312302144, 123:2, (44), . Saito H, Yokoyama K, Morimoto T, Ota H and Ikeda N (2022) Influences of COVID-19 pandemic and the states of emergency on occupational therapy for physical disorders: A questionnaire survey in Hokkaido, Japan, Hong Kong Journal of Occupational Therapy, 10.1177/15691861221121525, 35:2, (159-167), Online publication date: 1-Dec-2022. Siu M, Lin A, Narvaez V, Perez-Coulter A, Norris M, Kronick M, Hadro N, Kravetz A, Ching Y and Morris M (2022) Analysis of Presentation and Outcomes in Acute Limb Ischemia Patients During COVID-19 State of Emergency, Vascular and Endovascular Surgery, 10.1177/15385744221106272, 56:7, (665-673), Online publication date: 1-Oct-2022. İSKENDER N, AYDIN N, KARAOĞLANOĞLU S, OKTAY E, ERSÖZ B and ÖZARSLANTÜRK S (2022) Examination of Knowledge and Stress Levels of Patients and Reasons for the Application for Dental Treatments during COVID-19 Pandemic, Journal of Basic and Clinical Health Sciences, 10.30621/jbachs.1032876, 6:3, (863-871) Murakami T, Higuchi Y, Ueda T, Kozuki W and Gen A (2022) Internet-Based Information Sharing With Families of Patients With Stroke in a Rehabilitation Hospital During the COVID-19 Pandemic: Case-Control Study, JMIR Rehabilitation and Assistive Technologies, 10.2196/38489, 9:3, (e38489) Al-Amer R, Ramjan L, Maneze D, Al-Rashdan O, Villarosa A, Salamonson Y and George A (2022) The impact of a pandemic on dental professionals' work and personal lives: A qualitative study with implications for primary healthcare workers, Frontiers in Public Health, 10.3389/fpubh.2022.963410, 10 Schlachetzki F, Theek C, Hubert N, Kilic M, Haberl R, Linker R and Hubert G (2020) Low stroke incidence in the TEMPiS telestroke network during COVID-19 pandemic: Effect of lockdown on thrombolysis and thrombectomy, Journal of Telemedicine and Telecare, 10.1177/1357633X20943327, 28:7, (481-487), Online publication date: 1-Aug-2022. Tugasworo D, Kurnianto A, Retnaningsih , Andhitara Y, Ardhini R and Budiman J (2022) The relationship between myasthenia gravis and COVID-19: a systematic review, The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 10.1186/s41983-022-00516-3, 58:1 Medina-Rioja R, González-Calderón G, Saldívar-Dávila S, Estrada Saúl A, Gayón-Lombardo E, Somerville-Briones N and Calleja-Castillo J (2022) Grace Under Pressure: Resiliency of Quality Monitoring of Stroke Care During the Covid-19 Pandemic in Mexico City, Frontiers in Neurology, 10.3389/fneur.2022.831735, 13 Lele A, Wahlster S, Alunpipachathai B, Awraris Gebrewold M, Chou S, Crabtree G, English S, Der-Nigoghossian C, Gagnon D, Kim-Tenser M, Karanjia N, Kirkman M, Lamperti M, Livesay S, Mejia-Mantilla J, Melmed K, Prabhakar H, Tumino L, Venkatasubba Rao C, Udy A, Videtta W and Moheet A (2021) Perceptions Regarding the SARS-CoV-2 Pandemic's Impact on Neurocritical Care Delivery: Results From a Global Survey, Journal of Neurosurgical Anesthesiology, 10.1097/ANA.0000000000000825, 34:2, (209-220), Online publication date: 1-Apr-2022. Simonetto M, Wechsler P and Merkler A (2022) Stroke Treatment in the Era of COVID-19: a Review, Current Treatment Options in Neurology, 10.1007/s11940-022-00713-8, 24:4, (155-171), Online publication date: 1-Apr-2022. Geng D, Xu X, Luan X, Qiu L, Chen L, Chen J, Wu B, Xu M, Ergashev A, Tang W and Li J (2022) Differential Influence of the COVID-19 Pandemic on Mechanical Thrombectomy and Bridging Therapy for Acute Ischemic Stroke, Frontiers in Neurology, 10.3389/fneur.2022.852423, 13 Huo X, Raynald , Sun X, Mo D, Gao F, Ma N, Wang Y, Wang Y and Miao Z (2021) Influence of coronavirus disease 2019 (COVID-19) on working flow, safety and efficacy outcome of mechanical thrombectomy for acute ischemic stroke with large vessel occlusion, Interventional Neuroradiology, 10.1177/15910199211018093, 28:1, (58-64), Online publication date: 1-Feb-2022. Burton E, Aladkhen J, O'Donnell C, Masterson S, Merwick A, McCarthy V, Kearney P and Buckley C (2022) Effects of the COVID-19 pandemic on prehospital emergency care for adults with stroke and transient ischaemic attack: A protocol for a systematic review and meta-analysis, HRB Open Research, 10.12688/hrbopenres.13534.2, 5, (24) Burton E, McCarthy V, Merwick A, Kearney P and Buckley C (2022) Effects of the COVID-19 pandemic on prehospital emergency care for stroke and transient ischaemic attack: A protocol for a systematic review and meta-analysis, HRB Open Research, 10.12688/hrbopenres.13534.1, 5, (24) Kar A, Bhaumik U, Kumar V, Shwetha V and Nagaraja S (2021) Routine personal protective equipment in COVID-19 pandemic: What dentists need to know, Journal of Global Oral Health, 10.25259/JGOH_54_2020, 4, (102-106) Kurnianto A, Tugasworo D, Andhitara Y, Retnaningsih , Ardhini R and Budiman J (2021) Mechanical thrombectomy (MT) for acute ischemic stroke (AIS) in COVID-19 pandemic: a systematic review, The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 10.1186/s41983-021-00321-4, 57:1, Online publication date: 1-Dec-2021. Zhou S, Dong X, Liu F, Zhang Y, Yue D, Zhou Q, Jin Y and Zheng Z (2021) A stepped wedge cluster randomized control trial to evaluate the implementation and effectiveness of optimized initiatives in improving quality of care for ST segment elevation myocardial infarction in response to the COVID-19 outbreak, Implementation Science, 10.1186/s13012-021-01107-1, 16:1, Online publication date: 1-Dec-2021. Sharma S, Jagadeesh H, Saxena A, Chakravarthy H and Devanathan V (2021) Central nervous system as a target of novel coronavirus infections: Potential routes of entry and pathogenic mechanisms, Journal of Biosciences, 10.1007/s12038-021-00232-9, 46:4, Online publication date: 1-Dec-2021. Zureigat H, Alhusban M and Cobia M (2021)(2021) Mechanical Thrombectomy Outcomes in COVID-19 Patients With Acute Ischemic Stroke, The Neurologist, 10.1097/NRL.0000000000000360, 26:6, (261-267) Peng G, Nie X, Liebeskind D, Liu L and Miao Z (2021) Management of endovascular therapy for acute ischemic stroke amid the COVID-2019 pandemic: a multicenter survey in China, Neurological Research, 10.1080/01616412.2021.1939236, 43:10, (823-830), Online publication date: 3-Oct-2021. Leslie-Mazwi T and Srivatanakul K (2021) Coronavirus disease 2019 and stroke, Interventional Neuroradiology, 10.1177/15910199211035920, 27:1_suppl, (13-18), Online publication date: 1-Oct-2021. Vollmuth C, Miljukov O, Abu‐Mugheisib M, Angermaier A, Barlinn J, Busetto L, Grau A, Guenther A, Gumbinger C, Hubert N, Hüttemann K, Klingner C, Naumann M, Palm F, Remi J, Rücker V, Schessl J, Schlachetzki F, Schuppner R, Schwab S, Schwartz A, Trommer A, Urbanek C, Volbers B, Weber J, Wojciechowski C, Worthmann H, Zickler P, Heuschmann P, Haeusler K and Hubert G (2021) Impact of the coronavirus disease 2019 pandemic on stroke teleconsultations in Germany in the first half of 2020, European Journal of Neurology, 10.1111/ene.14787, 28:10, (3267-3278), Online publication date: 1-Oct-2021. Marín-Medina D, Muñoz-Rosero A, Bernal-Bastidas B and Gaspar-Toro J (2021) Infección por SARS-CoV-2 y ataque cerebrovascular isquémico, Medicina de Familia. SEMERGEN, 10.1016/j.semerg.2020.09.007, 47:7, (482-487), Online publication date: 1-Oct-2021. Alonso de Leciñana M (2021) Impacto de la pandemia COVID-19 en la atención al ictus, Hipertensión y Riesgo Vascular, 10.1016/j.hipert.2021.08.001, 38:4, (161-163), Online publication date: 1-Oct-2021. Böjti P, Szilágyi G, Dobi B, Stang R, Szikora I, Kis B, Kornfeld Á, Óváry C, Erőss L, Banczerowski P, Kuczyński W and Bereczki D (2021) Impact of COVID-19 on ischemic stroke care in Hungary, GeroScience, 10.1007/s11357-021-00424-z, 43:5, (2231-2248), Online publication date: 1-Oct-2021. Pezzini A, Grassi M, Silvestrelli G, Locatelli M, Rifino N, Beretta S, Gamba M, Raimondi E, Giussani G, Carimati F, Sangalli D, Corato M, Gerevini S, Masciocchi S, Cortinovis M, La Gioia S, Barbieri F, Mazzoleni V, Pezzini D, Bonacina S, Pilotto A, Benussi A, Magoni M, Premi E, Prelle A, Agostoni E, Palluzzi F, De Giuli V, Magherini A, Roccatagliata D, Vinciguerra L, Puglisi V, Fusi L, Xhani R, Pozzi F, Diamanti S, Santangelo F, Grampa G, Versino M, Salmaggi A, Marcheselli S, Cavallini A, Giossi A, Censori B, Ferrarese C, Ciccone A, Sessa M and Padovani A (2021) Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network, Journal of Neurology, 10.1007/s00415-021-10497-7, 268:10, (3561-3568), Online publication date: 1-Oct-2021. Grigonyte M, Kraujelyte A, Januskeviciute E, Semys G, Kriukelyte O, Kontrimaviciute E, Valeviciene N and Jatuzis D (2021) The Impact of the Pandemic on Acute Ischaemic Stroke Endovascular Treatment from a Multidisciplinary Perspective: A Nonsystematic Review, International Journal of Environmental Research and Public Health, 10.3390/ijerph18189464, 18:18, (9464) Zhao J and Liu R (2021) Promoting stroke awareness through short movies and film festivals, CNS Neuroscience & Therapeutics, 10.1111/cns.13710, 27:9, (991-993), Online publication date: 1-Sep-2021. Pujol-Lereis V, Flores A, Barboza M, Abanto-Argomedo C, Amaya P, Bayona H, Bonardo P, Diaz-Escobar L, Gomez-Schneider M, Góngora-Rivera F, Lavados P, Leon C, Luraschi A, Marquez-Romero J, Ouriques-Martins S, Navia V, Ruiz-Franco A, Vences M, Zurrú M, Arauz A and Ameriso S (2021) COVID-19 Lockdown Effects on Acute Stroke Care in Latin America, Journal of Stroke and Cerebrovascular Diseases, 10.1016/j.jstrokecerebrovasdis.2021.105985, 30:9, (105985), Online publication date: 1-Sep-2021. Bouali‐Benazzouz R and Benazzouz A (2021) Covid‐19 Infection and Parkinsonism: Is There a Link?, Movement Disorders, 10.1002/mds.28680, 36:8, (1737-1743), Online publication date: 1-Aug-2021. Rapoport M, Chee J, Aljenabi N, Byrne P, Naglie G, Ilari F, Elzohairy Y, Vingilis E and Mulsant B (2021) Impact of COVID-19 on motor vehicle injuries and fatalities in older adults in Ontario, Canada, Accident Analysis & Prevention, 10.1016/j.aap.2021.106195, 157, (106195), Online publication date: 1-Jul-2021. Bersano A and Pantoni L (2020) Stroke care in Italy at the time of the COVID-19 pandemic: a lesson to learn, Journal of Neurology, 10.1007/s00415-020-10200-2, 268:7, (2307-2313), Online publication date: 1-Jul-2021. Wang J, Hong Y, Ma M, Zhou M, Guo J, Chen N, Fang J, Liu W, Zhang Y, Chen L, Hao N, Wang Y, Zhou D and He L (2021) Mitigating the impact of coronavirus disease 2019 on emergency stroke care: an original study and meta-analysis, Reviews in the Neurosciences, 10.1515/revneuro-2020-0097, 32:4, (443-457), Online publication date: 25-Jun-2021., Online publication date: 1-Jun-2021. Ozturk S (2021) COVID-19 and Stroke: A Neurological Perspective Stroke, 10.36255/exonpublications.stroke.covid19.2021, (171-178) Douiri A, Muruet W, Bhalla A, James M, Paley L, Stanley K, Rudd A, Wolfe C and Bray B (2021) Stroke Care in the United Kingdom During the COVID-19 Pandemic, Stroke, 52:6, (2125-2133), Online publication date: 1-Jun-2021. Alonso de Leciñana M, Castellanos M, Ayo-Martín Ó and Morales A (2020) Stroke care during the COVID-19 outbreak in Spain: the experience of Spanish stroke units, Stroke and Vascular Neurology, 10.1136/svn-2020-000678, 6:2, (267-273), Online publication date: 1-Jun-2021. Aboul Nour H, Affan M, Mohamed G, Mohamud A, Schultz L, Latack K, Brady M, Scozzari D, Haddad Y, Katramados A, Bou Chebl A and Ramadan A (2021) Impact of the COVID-19 Pandemic on Acute Stroke Care, Time Metrics, Outcomes, and Racial Disparities in a Southeast Michigan Health System, Journal of Stroke and Cerebrovascular Diseases, 10.1016/j.jstrokecerebrovasdis.2021.105746, 30:6, (105746), Online publication date: 1-Jun-2021. Camargo-Martínez W, Lozada-Martínez I, Escobar-Collazos A, Navarro-Coronado A, Moscote-Salazar L, Pacheco-Hernández A, Janjua T and Bosque-Varela P (2021) Post-COVID 19 neurological syndrome: Implications for sequelae's treatment, Journal of Clinical Neuroscience, 10.1016/j.jocn.2021.04.001, 88, (219-225), Online publication date: 1-Jun-2021. Khosravi B, Moradveisi B, Abedini M, Behzadi S and Karimi A (2021) Stroke in a child with SARS-CoV-2 infection: A case report, eNeurologicalSci, 10.1016/j.ensci.2021.100345, 23, (100345), Online publication date: 1-Jun-2021. Ostrowska P, Śliwiński M, Studnicki R and Hansdorfer-Korzon R (2021) Telerehabilitation of Post-Stroke Patients as a Therapeutic Solution in the Era of the Covid-19 Pandemic, Healthcare, 10.3390/healthcare9060654, 9:6, (654) Loh H, Neoh K, Tang A, Chin C, Suppiah P, Looi I, Goh K, Tan C and Ming L (2021) Stroke Patients' Characteristics and Clinical Outcomes: A Pre-Post COVID-19 Comparison Study, Medicina, 10.3390/medicina57050507, 57:5, (507) Alekseeva E, Tepaev R, Shilkrot I, Dvoryakovskaya T, Surkov A and Kriulin I (2021) COVID-19-associated secondary hemophagocytic lymphohistiocytosis (cytokine storm syndrome), Annals of the Russian academy of medical sciences, 10.15690/vramn1410, 76:1, (51-66) Saban M, Reznik A, Shachar T, Wilf-Miron R and Sivan-Hoffmann R (2021) The effect of the COVID-19 pandemic on ED referrals and care for stroke patients: A four-year comparative study, Journal of Critical Care, 10.1016/j.jcrc.2020.12.011, 62, (230-234), Online publication date: 1-Apr-2021. Presl J, Varga M, Mittermair C, Mitterwallner S, Weitzendorfer M, Gabersek A, Borhanian K, Heuberger A, Weiss H, Emmanuel K, von Rahden B and Koch O (2021) Impact of the COVID-19 pandemic lockdown on the utilization of acute surgical care in the State of Salzburg, Austria: retrospective, multicenter analysis, European Surgery, 10.1007/s10353-021-00692-1, 53:2, (48-54), Online publication date: 1-Apr-2021. Li M, Lang M, Deng F, Chang K, Buch K, Rincon S, Mehan W, Leslie-Mazwi T and Kalpathy-Cramer J (2020) Analysis of Stroke Detection during the COVID-19 Pandemic Using Natural Language Processing of Radiology Reports, American Journal of Neuroradiology, 10.3174/ajnr.A6961, 42:3, (429-434), Online publication date: 1-Mar-2021. Xiao Y, Wang Y, Zhu W, Yao J, Sun C, Militky J, Venkataraman M and Zhu G (2021) Development of tree-like nanofibrous air filter with durable antibacterial property, Separation and Purification Technology, 10.1016/j.seppur.2020.118135, 259, (118135), Online publication date: 1-Mar-2021. Abenza Abildúa M, Atienza S, Carvalho Monteiro G, Erro Aguirre M, Imaz Aguayo L, Freire Álvarez E, García-Azorín D, Gil-Olarte Montesinos I, Lara Lezama L, Navarro Pérez M, Pérez Sánchez J, Romero Delgado F, Serrano Serrano B, Villarreal Vitorica E and Ezpeleta Echávarri D (2021) Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology's COVID-19 Registry, Neurología (English Edition), 10.1016/j.nrleng.2020.11.003, 36:2, (127-134), Online publication date: 1-Mar-2021. Abenza Abildúa M, Atienza S, Carvalho Monteiro G, Erro Aguirre M, Imaz Aguayo L, Freire Álvarez E, García-Azorín D, Gil-Olarte Montesinos I, Lara Lezama L, Navarro Pérez M, Pérez Sánchez J, Romero Delgado F, Serrano Serrano B, Villarreal Vitorica E and Ezpeleta Echávarri D (2021) Encefalopatías y encefalitis durante la infección aguda por SARS-CoV2. Registro de la Sociedad Española de Neurología SEN COVID-19, Neurología, 10.1016/j.nrl.2020.11.013, 36:2, (127-134), Online publication date: 1-Mar-2021. Iodice F, Romoli M, Giometto B, Clerico M, Tedeschi G, Bonavita S, Leocani L and Lavorgna L (2021) Stroke and digital technology: a wake-up call from COVID-19 pandemic, Neurological Sciences, 10.1007/s10072-020-04993-3, 42:3, (805-809), Online publication date: 1-Mar-2021. Podury A, Raefsky S, Dodakian L, McCafferty L, Le V, McKenzie A, See J, Zhou R, Nguyen T, Vanderschelden B, Wong G, Nazarzai L, Heckhausen J, Cramer S and Dhand A (2021) Social Network Structure Is Related to Functional Improvement From Home-Based Telerehabilitation After Stroke, Frontiers in Neurology, 10.3389/fneur.2021.603767, 12 Fuentes B, Alonso de Leciñana M, García-Madrona S, Díaz-Otero F, Aguirre C, Calleja P, Egido J, Carneado-Ruiz J, Ruiz-Ares G, Rodríguez-Pardo J, Rodríguez-López Á, Ximénez-Carrillo Á, de Felipe A, Ostos F, González-Ortega G, Simal P, Gómez Escalonilla C, Gómez-Porro-Sánchez P, Desanvicente Z, Reig G, Gil-Núñez A, Masjuán J and Díez-Tejedor E (2021) Stroke Acute Management and Outcomes During the COVID-19 Outbreak, Stroke, 52:2, (552-562), Online publication date: 1-Feb-2021. Deliwala S, Hussain M, Ponnapalli A, Awuah D, Dawood T and Bachuwa G (2021) Acute confusional state as a prognostic sign of COVID-19 large-vessel occlusion (LVO), BMJ Case Reports, 10.1136/bcr-2020-240536, 14:2, (e240536), Online publication date: 1-Feb-2021. Baracchini C and Pieroni A (2020) Acute stroke treatment during coronavirus disease 2019 pandemic, Current Opinion in Neurology, 10.1097/WCO.0000000000000886, 34:1, (11-17), Online publication date: 1-Feb-2021. Logroscino G and Beghi E (2020) Stroke epidemiology and COVID-19 pandemic, Current Opinion in Neurology, 10.1097/WCO.0000000000000879, 34:1, (3-10), Online publication date: 1-Feb-2021. Shah S, Dharia R, Stazi J, DePrince M and Rosenwasser R (2021) Rapid Decline in Telestroke Consults in the Setting of COVID-19, Telemedicine and e-Health, 10.1089/tmj.2020.0229, 27:2, (227-230), Online publication date: 1-Feb-2021. Tavanaei R, Yazdani K, Akhlaghpasand M, Zali A and Oraee-Yazdani S (2021) Changed pattern of hospital admission in stroke during COVID-19 pandemic period in Iran: a retrospective study, Neurological Sciences, 10.1007/s10072-020-05030-z, 42:2, (445-453), Online publication date: 1-Feb-2021. Luo W, Li J, Li Z, Luo X, Chen M and Cai C (2021) Effects of the COVID-19 pandemic on reperfusion therapy for acute ischemic stroke patients in Huizhou City, China, Neurological Sciences, 10.1007/s10072-020-04938-w, 42:2, (467-473), Online publication date: 1-Feb-2021. Katsanos A, Palaiodimou L, Zand R, Yaghi S, Kamel H, Navi B, Turc G, Romoli M, Sharma V, Mavridis D, Shahjouei S, Catanese L, Shoamanesh A, Vadikolias K, Tsioufis K, Lagiou P, Alexandrov A, Tsiodras S and Tsivgoulis G (2020) The Impact of SARS‐CoV ‐2 on Stroke Epidemiology and Care: A Meta‐Analysis , Annals of Neurology, 10.1002/ana.25967, 89:2, (380-388), Online publication date: 1-Feb-202

Impacts of Population Aging on the Subtypes of Stroke.

Treatment and 1-Year Prognosis of Ischemic Stroke in China in 2018: A Hospital-Based Study from Bigdata Observatory Platform for Stroke of China

Has Stroke Shifted from Hemorrhagic to Ischemic in China?

Increasing burden of stroke in China: A systematic review and meta-analysis of prevalence, incidence, mortality, and case fatality

The Association of Stage 1 Hypertension Defined by the 2017 ACC/AHA Guideline with Stroke and Its Subtypes among Elderly Chinese

Changing Patterns of Stroke and Subtypes Attributable to High Systolic Blood Pressure in China From 1990 to 2019

Temporal Trend and Attributable Risk Factors of Stroke Burden in China, 1990-2019: Findings from the Global Burden of Disease Study 2019

Age And Gender Variations In The Management Of Ischaemic Stroke In China

Trends in stroke subtypes and vascular risk factors in a stroke center in China over 10 years

Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019

Risk Factors for Incident Stroke and Its Subtypes in China: A Prospective Study

Abstract P396: Hospital Management of Major Stroke Types in Urban and Rural China: Findings from a 11-Year Community-Based Studies Involving >20,000 Hospitalized Stroke Cases

Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak

Incidence and Trends of Stroke and Its Subtypes in China

Risk Factors of Incident Total Stroke and Ischemic Stroke in China

Temporal trends and rural-urban disparities in cerebrovascular risk factors, in-hospital management and outcomes in ischaemic strokes in China from 2005 to 2015: a nationwide serial cross-sectional survey

Stroke in China: Epidemiology, Prevention, and Management Strategies

Age and Geographic Disparities in Acute Ischaemic Stroke Prehospital Delays in China: a Cross-Sectional Study Using National Stroke Registry Data

Prevalence and risk factors of stroke in China: a national serial cross-sectional study from 2003 to 2018